Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis

BackgroundRheumatoid arthritis (RA) and depression are prevalent diseases that have a negative impact on the quality of life and place a significant economic burden on society. There is increasing evidence that the two diseases are closely related, which could make the disease outcomes worse. In thi...

Full description

Bibliographic Details
Main Authors: Tao-tao Zhou, Ji-jia Sun, Li-dong Tang, Ying Yuan, Jian-ying Wang, Lei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1007624/full
_version_ 1797897126640877568
author Tao-tao Zhou
Ji-jia Sun
Li-dong Tang
Ying Yuan
Jian-ying Wang
Lei Zhang
author_facet Tao-tao Zhou
Ji-jia Sun
Li-dong Tang
Ying Yuan
Jian-ying Wang
Lei Zhang
author_sort Tao-tao Zhou
collection DOAJ
description BackgroundRheumatoid arthritis (RA) and depression are prevalent diseases that have a negative impact on the quality of life and place a significant economic burden on society. There is increasing evidence that the two diseases are closely related, which could make the disease outcomes worse. In this study, we aimed to identify diagnostic markers and analyzed the therapeutic potential of key genes.MethodsWe assessed the differentially expressed genes (DEGs) specific for RA and Major depressive disorder (MDD) and used weighted gene co-expression network analysis (WGCNA) to identify co-expressed gene modules by obtaining the Gene expression profile data from Gene Expression Omnibus (GEO) database. By using the STRING database, a protein–protein interaction (PPI) network constructed and identified key genes. We also employed two types of machine learning techniques to derive diagnostic markers, which were assessed for their association with immune cells and potential therapeutic effects. Molecular docking and in vitro experiments were used to validate these analytical results.ResultsIn total, 48 DEGs were identified in RA with comorbid MDD. The PPI network was combined with WGCNA to identify 26 key genes of RA with comorbid MDD. Machine learning-based methods indicated that RA combined with MDD is likely related to six diagnostic markers: AURKA, BTN3A2, CXCL10, ERAP2, MARCO, and PLA2G7. CXCL10 and MARCO are closely associated with diverse immune cells in RA. However, apart from PLA2G7, the expression levels of the other five genes were associated with the composition of the majority of immune cells in MDD. Molecular docking and in vitro studies have revealed that Aucubin (AU) exerts the therapeutic effect through the downregulation of CXCL10 and BTN3A2 gene expression in PC12 cells.ConclusionOur study indicates that six diagnostic markers were the basis of the comorbidity mechanism of RA and MDD and may also be potential therapeutic targets. Further mechanistic studies of the pathogenesis and treatment of RA and MDD may be able to identify new targets using these shared pathways.
first_indexed 2024-04-10T07:53:46Z
format Article
id doaj.art-ffa2f9f407df4d26a7736fb091dc6540
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T07:53:46Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ffa2f9f407df4d26a7736fb091dc65402023-02-23T07:29:51ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-02-011410.3389/fimmu.2023.10076241007624Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysisTao-tao Zhou0Ji-jia Sun1Li-dong Tang2Ying Yuan3Jian-ying Wang4Lei Zhang5Department of Mathematics and Physics, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Mathematics and Physics, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaTeaching and Research Section of Chinese Materia Medica, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaTeaching and Research Section of Chinese Materia Medica, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaShanghai Innovation Center of Traditional Chinese Medicine Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaShanghai Innovation Center of Traditional Chinese Medicine Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaBackgroundRheumatoid arthritis (RA) and depression are prevalent diseases that have a negative impact on the quality of life and place a significant economic burden on society. There is increasing evidence that the two diseases are closely related, which could make the disease outcomes worse. In this study, we aimed to identify diagnostic markers and analyzed the therapeutic potential of key genes.MethodsWe assessed the differentially expressed genes (DEGs) specific for RA and Major depressive disorder (MDD) and used weighted gene co-expression network analysis (WGCNA) to identify co-expressed gene modules by obtaining the Gene expression profile data from Gene Expression Omnibus (GEO) database. By using the STRING database, a protein–protein interaction (PPI) network constructed and identified key genes. We also employed two types of machine learning techniques to derive diagnostic markers, which were assessed for their association with immune cells and potential therapeutic effects. Molecular docking and in vitro experiments were used to validate these analytical results.ResultsIn total, 48 DEGs were identified in RA with comorbid MDD. The PPI network was combined with WGCNA to identify 26 key genes of RA with comorbid MDD. Machine learning-based methods indicated that RA combined with MDD is likely related to six diagnostic markers: AURKA, BTN3A2, CXCL10, ERAP2, MARCO, and PLA2G7. CXCL10 and MARCO are closely associated with diverse immune cells in RA. However, apart from PLA2G7, the expression levels of the other five genes were associated with the composition of the majority of immune cells in MDD. Molecular docking and in vitro studies have revealed that Aucubin (AU) exerts the therapeutic effect through the downregulation of CXCL10 and BTN3A2 gene expression in PC12 cells.ConclusionOur study indicates that six diagnostic markers were the basis of the comorbidity mechanism of RA and MDD and may also be potential therapeutic targets. Further mechanistic studies of the pathogenesis and treatment of RA and MDD may be able to identify new targets using these shared pathways.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1007624/fullrheumatoid arthritisdepressionbioinformaticsmachine learningmolecular docking
spellingShingle Tao-tao Zhou
Ji-jia Sun
Li-dong Tang
Ying Yuan
Jian-ying Wang
Lei Zhang
Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
Frontiers in Immunology
rheumatoid arthritis
depression
bioinformatics
machine learning
molecular docking
title Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
title_full Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
title_fullStr Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
title_full_unstemmed Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
title_short Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
title_sort potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
topic rheumatoid arthritis
depression
bioinformatics
machine learning
molecular docking
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1007624/full
work_keys_str_mv AT taotaozhou potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis
AT jijiasun potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis
AT lidongtang potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis
AT yingyuan potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis
AT jianyingwang potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis
AT leizhang potentialdiagnosticmarkersandtherapeutictargetsforrheumatoidarthritiswithcomorbiddepressionbasedonbioinformaticsanalysis